Price T Rowe Associates Inc Becton Dickinson & CO Transaction History

Price T Rowe Associates Inc

$935 Billion
Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,622,537 shares of BDX stock, worth $883 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,622,537

Previous 8,883,774 47.97%

Holding current value

$883 Million

Previous $1.53 Billion 43.46%

% of portfolio

0.09%

Previous 0.17%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$172.41 - $199.66 $735 Million - $851 Million	-4,261,237 Reduced 47.97%	4,622,537 $865 Million
Q2 2025 Aug 14, 2025	SELL	$165.15 - $226.42 $401 Million - $550 Million	-2,430,362 Reduced 21.48%	8,883,774 $1.53 Billion
Q1 2025 May 14, 2025	SELL	$222.79 - $249.08 $230 Million - $257 Million	-1,032,608 Reduced 8.36%	11,314,136 $2.59 Billion
Q4 2024 Feb 14, 2025	SELL	$220.02 - $243.75 $275 Million - $305 Million	-1,251,742 Reduced 9.21%	12,346,744 $2.8 Billion
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $632 Million - $692 Million	2,854,304 Added 26.57%	13,598,486 $3.28 Billion

Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $140 Million - $154 Million	623,855 Added 6.16%	10,744,182 $2.51 Billion
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $62 Million - $65.8 Million	-265,561 Reduced 2.56%	10,120,327 $2.5 Billion
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $582 Million - $670 Million	-2,506,539 Reduced 19.44%	10,385,888 $2.53 Billion
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $344 Million - $382 Million	-1,348,554 Reduced 9.47%	12,892,427 $3.33 Billion
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $164 Million - $182 Million	-686,853 Reduced 4.6%	14,240,981 $3.76 Billion
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $746 Million - $842 Million	-3,247,724 Reduced 17.87%	14,927,834 $3.7 Billion
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $582 Million - $685 Million	-2,667,231 Reduced 12.8%	18,175,558 $4.62 Billion
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $305 Million - $1.58 Billion	-5,971,622 Reduced 22.27%	20,842,789 $4.64 Billion
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $3.28 Billion - $3.85 Billion	13,965,418 Added 108.69%	26,814,411 $6.61 Billion
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $1.58 Billion - $1.75 Billion	-6,475,705 Reduced 33.51%	12,848,993 $3.42 Billion
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $894 Million - $975 Million	3,884,437 Added 25.16%	19,324,698 $4.86 Billion
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $572 Million - $630 Million	2,457,473 Added 18.93%	15,440,261 $3.8 Billion
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $617 Million - $676 Million	2,654,142 Added 25.7%	12,982,788 $3.16 Billion
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $304 Million - $336 Million	-1,309,456 Reduced 11.25%	10,328,646 $2.51 Billion
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $2.58 Billion - $2.86 Billion	11,638,102 New	11,638,102 $2.91 Billion

Others Institutions Holding BDX

# of Institutions

1,718

Shares Held

257M

Call Options Held

1.01M

Put Options Held

544K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $54.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Becton Dickinson & CO Transaction History